Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation. Shinzaki S, Sato T, Fukui H. J Gastroenterol 2023;58:598-599.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shinzaki S, Sato T, Fukui H. Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation. J Gastroenterol 2023;58:598-599.
PMID: 36961556